See All ProEducar “José Gabay” Course (Eighth Edition) Presentations

We are deeply thankful to all interventional physicians who, motivated by their great scientific and educational vocation, presented their works at the “José Gabay” Course and actively collaborated in training and providing updated concepts for the next generations of interventional cardiologists.

presentaciones ProEducar

Read and/or download the presentations below:

 

Module I: Fundamentals and Basic Elements.

  • Álvarez, José. “Transfemoral and Transradial Access. Step by Step. Complications”.

  (Spanish version)

  • Vignolo, Gustavo. “Pre/Post-Stent Antiplatelet Therapy. Drugs, Doses, and Time. “.

  (Spanish version) 

 

Module II: Complex Coronary Interventions. Tips and Secrets of the Trade.

  • Lluberas, Ricardo. “Primary Angioplasty: How Do We Obtain the Best Flow? Techniques and Step by Step Demonstrations”.

  (Spanish version).

  • Berrocal, Daniel. “Treatment of Bifurcation Lesions. When and How Do We Use ONE or TWO Stents? Educational Case”.

  (Spanish version).

 

Module III: Diagnostic Tools in the Cath Lab.

  • Costa, Ribamar. “Integration of Diagnostic Methods in the Cath Lab”.

  (Spanish version).

  • Telayna, Juan. “When and How Should We Use IVUS? Step by step”.

  (Spanish version).

 

Module IV: Peripheral Interventions.

  • Mandil, Ari. “Carotid Artery Stenting. Treatment Techniques. Step by Step.”

  (Spanish version).

  • Londero, Hugo. “Exclusion of an Abdominal Aortic Aneurysm. Lessons for Proper Technique”.

 (Spanish version).

  • Valdivieso, León. “Suprapatellar Lesions. Treatment Indications. Stents, Drug-Eluting Balloons, Surgery…”.

 (Spanish version).

 

Module V: Structural Heart Disease

  • Damonte, Anibal. “Appendage Closure. Treatment Technique. Step by Step”.

 (Spanish version).

  • Méndiz Oscar. “Aortic Valve Implantation. Current Valve Types. Patient Selection.”

 (Spanish version).

  • Ribeiro, Henrique. “Mitral Valve Intervention. Current Data and Future Expectations”

 (Spanish version).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...